Jan 27, 2015
DUBLIN, Jan. 27, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on March 17, 2015 to shareholders of record on February 27, 2015.
From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquartered in Ireland, has grown to become a leading global healthcare supplier. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products and active pharmaceutical ingredients (API), and receives royalties from Multiple Sclerosis drug Tysabri®. The Company is the world's largest manufacturer of OTC healthcare products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo's mission is to offer uncompromised "Quality Affordable Healthcare Products®" and it does so across a wide variety of product categories primarily in the United States, United Kingdom, Mexico, Israel and Australia, as well as more than 40 other key markets worldwide, including Canada, China and Latin America. Visit Perrigo on the Internet (http://www.perrigo.com).
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/perrigo-company-plc-announces-quarterly-dividend-300026173.html
For further information: Arthur J. Shannon, Vice President, Investor Relations and Global Communications, (269) 686-1709, E-mail: email@example.com; Bradley Joseph, Director, Investor Relations and Global Communications, (269) 686-3373, E-mail: firstname.lastname@example.org